The portable device runs an isothermal amplification assay to detect genetic material from strains of tuberculosis in resource limited areas.
The investment bank noted that Hologic could be the "biggest beneficiary from tax reform" in its coverage with a potential 8 percent benefit to earnings per share.
Abbott's Alinity h-series system integrates a standalone hematology analyzer and slide maker-and-stainer module to enable high-throughput complete blood counting.
There were 58 M&A deals in the diagnostics space during the year, paced by Quest, which announced 12 deals. Abbott's $5.3 billion buy of Alere was the biggest acquisition.
Siemens noted that in closing the acquisition of Epocal, the former Alere subsidiary, it has also completed its own blood gas portfolio.
The integrated instrument system runs clinical chemistry tests and immunoassays with a high throughput and small footprint.
A study found that the use of a blood test instead of urine decreased time to diagnosis and improved outcomes associated with missed pregnancy diagnoses.
Overall, the company reported its total revenues grew 29 percent year over year to $6.83 billion. It also said that it is reorganizing the Alere business, completed earlier this month.
Abbott is accused of infringing IP related to a method for detecting HIV-2 antibodies and of violating the terms of a licensing deal related to the patent.